Onyx Pharmaceuticals (ONXX) finishes the day up a solid 11.7% to $76.38 today, after the the FDA...

|By:, SA News Editor

Onyx Pharmaceuticals (ONXX) finishes the day up a solid 11.7% to $76.38 today, after the the FDA approved midday it's Kyprolis for patients with multiple myeloma, the second most common hematologic cancer. The treatment "provides clinicians the opportunity to help these patients who until now had no effective options," the firm noted in a statement.